Epithelial-mesenchymal transition is associated with CD44 high/CD24 low-expressing breast cancer stem and stem-like cells [37, 38], and CD44 was part of the GSEA Hallmarks EMT gene set found enriched among the differentially expressed genes in DIP2C−/− cells. Here, CD24 is linked to breast carcinoma.